Molecular oncology · 2026
European Code Against Cancer, 5th edition - organised cancer screening programmes.
СтатьяОбзорПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Toes-Zoutendijk Esther, Arbyn Marc, Auvinen Anssi, Baldwin David, Castells Xavier, DeCensi Andrea, Hofvind Solveig, Ivanus Urska, Senore Carlo, Thorat Mangesh, van der Aalst Carlijn, Pinto Ana Carolina Pereira Nunes, Bracchiglione Javier, Feliu Ariadna, Zeeb Hajo, D'Souza Erica, Ritchie David, Espina Carolina, Carvalho Andre L, Lansdorp-Vogelaar Iris
Аннотация
The 5th edition of the European Code Against Cancer (ECAC5) recommends sustainable, organised screening programmes for: (a) colorectal cancer using biennial quantitative faecal immunochemical test (FIT) for individuals aged 50-74 years. As an alternative strategy, once-only endoscopy may be considered within the same age range; (b) breast cancer using biennial digital mammography for women aged 50-69 years. Implementing this strategy for women aged 45-49 years and 70-74 years can be considered. Other screening strategies or additional examinations could be considered for women with high mammographic density; (c) cervical cancer using human papillomavirus (HPV) screening at intervals no shorter than 5 years for women aged 30-65 years. It is recommended to adapt policies according to vaccination status and screening history; and (d) lung cancer using annual low-dose computed tomography (LDCT) for individuals considered to be at increased risk of lung cancer based on age, history of smoking or validated risk models, with biennial screening as an alternative. Screening should incorporate smoking cessation interventions.